Background:The Ministry of Health is drafting a policy that aims at integrating health services delivery for people above 60 years within the existing delivery structures in Uganda. To inform their …
Lakwo T,
Habomugisha P,
Byamukama E,
Tukahebwa E M,
Onapa A,
Tukesiga E,
Agunyo S,
Katabarwa M N,
Oguttu D,
Unoba D
and others...
2013
Journal,
Article
Health Research
The objective of the study was to determine whether annual ivermectin treatment in the Nyagak-Bondoonchocerciasis focus could safely be withdrawn. Baseline skin snip microfilariae (mf) and nodule prevalence data fromsix …
Lakwo T,
Ndyomugyenyi R,
Habomugisha P,
Byamukama E,
Onapa A,
Tukesiga E,
Katabarwa M,
Agunyo S,
Oguttu D,
Walsh F
and others...
2014
Journal,
Article
Health Research
The study determined that Simulium neavei-transmitted onchocerciasis in Mount Elgon onchocerciasisfocus had been interrupted. Annual mass treatment with ivermectin changed to two times per year along with vectorelimination in 2007. …
Habomugisha P,
Byamukama E,
Eyamba A,
Katabarwa M N,
Nwane P,
Arinaitwe A,
Musigire J,
Tushemereirwe R,
Khainza A
2015
Journal,
Article
Health Research
BackgroundThe community-directed intervention (CDI) approach has improved treatment coverage in onchocerciasis-affected communities. However, there is still a lot to learn. This study assessed its performance and highlighted the lessons learnt …
Lakwo T,
Habomugisha P,
Byamukama E,
Tukahebwa E,
Unnasch TR,
Tukesiga E,
Oguttu D,
Khainza A,
Katabarwa MN,
Katamanywa J
and others...
2016
Journal,
Article
Health Research
It was not until early 1990s that, when the Imaramagambo focus of southwest Uganda was mapped, mass treatment with a single annual dose of ivermectin for onchocerciaisis control commenced. However, …
Katabarwa M. N.,
Lakwo T.,
Zroug I.,
Kebede B.,
Habomugisha P. et al,
The Carter Center U. S. A.
2017
Journal,
Article
Health Research
AFRICAN DEVELOPMENT Abstract: As the shift from control to elimination of onchocerciasis progresses in Ethiopia, Sudan and Uganda, cross-border transmission has become an increasingly apparent obstacle to success. Without a …
Lakwo T,
Habomugisha P,
Byamukama E,
Tukahebwa E,
Unnasch TR,
Khainza A,
Katabarwa MN,
Richards FO,
Garms R,
Hudson-Davis L
and others...
2018
Journal,
Article
Health Research
Onchocerciasis causes severe itching, serious skin disease and ocular damage leading to visual impairment or permanent blindness. It is associated with hanging groin, epilepsy, Nakalanga dwarfism and, most recently, nodding …
Habomugisha P,
Byamukama E,
Eyamba A,
Katabarwa M N,
Richards F O,
Nwane P,
Khainza A,
Griswold E,
Bernard L,
Weiss P
2019
Journal,
Article
Health Research
Mass drug administration (MDA) with ivermectin must reach a high treatment coverage (90% of the eligiblepopulation) if onchocerciasis is to be eliminated. Questions have been raised as to whether reported …
Habomugisha P,
Byamukama E,
Unnasch TR,
Oguttu D,
Khainza A,
Katabarwa MN,
Katamanywa J,
Nahabwe C,
Ngabirano M,
Bernard L
and others...
2020
Journal,
Article
Health Research
Wambabya-Rwamarongo onchocerciasis focus is one of the eight foci Uganda verified using the WHO verification guidelines. The approach for elimination was twice yearly treatment with ivermectin for every round, treating …
Oguttu DW,
Habomugisha P,
Byamukama E,
Unnasch TR,
Khainza A,
Katabarwa MN,
Katamanywa J,
Nahabwe C,
Ngabirano M,
Bernard L
and others...
2020
Journal,
Article
Health Research
Uganda has verified elimination of seven onchocerciasis foci since 2007 when the nationwide onchocerciasis elimination policy was launched. However, the Victoria Nile focus (which was eliminated in the early 1970s) …
MEDLINE Abstract: Wambabya-Rwamarongo onchocerciasis focus is one of the eight foci Uganda verified using the WHO verification guidelines. The approach for elimination was twice yearly treatment with ivermectin for every …
